News
Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.
Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...
Activist investor Glenview Capital is reducing its stake in healthcare giant CVS Health following its first-quarter earnings ...
CVS Health delivered first-quarter results that beat Wall Street expectations, but said its Aetna unit plans to withdraw next ...
Oklahoma Attorney General joins three other states in filing a complaint against CVS Pharmacy. The complaint alleges the drugstore chain charged higher prices for prescriptions covered under Medicaid ...
Activist investor Glenview Capital Management sold 3.75 million shares of CVS Health Corp. and pledged to keep the rest, ...
Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...
Transitions of care—moving patients from one care site to another—continues to be a challenge in healthcare. | Startup Kouper ...
The complaint alleged that through a discount card program with ScriptSave, CVS customers who paid in cash received discounts ...
Attorney General Andrea Campbell and a few of her peers sued CVS on Wednesday, alleging the pharmacy giant for years failed to provide Medicaid members with access to ...
CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better ...
The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results